Back To: Home : Featured Technology : PCR/qPCR

CLICK HERE FOR WHAT'S NEW IN:
 

Qiagen and Abbott in MDx deal
November 2010
SHARING OPTIONS:

GERMANTOWN, Md.Qiagen and Abbott have announced an agreement for molecular tests for HIV, HCV and HPV. Qiagen will receive kits for a PCR-based molecular assay for HIV-1 viral load testing in the United States and Canada, which will be commercialized under Qiagen's brand. Abbott will provide a quantitative hepatitis C test that will be optimized and labeled for use on Qiagen's QIAsymphony RGQ instrument and marketed under the Abbott brand in the United States and Canada. Qiagen will supply Abbott with certain key products required for a PCR-based human papillomavirus test in the United States and Canada. According to the companies, their agreement significantly strengthens both companies' testing menus for automated in vitro diagnostic applications in North America. Financial terms were not disclosed.

Back


PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2017 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.